Abstract
Protein tyrosine phosphatase 1B (PTP1B) is a prototype non receptor cytoplasmic PTPase enzyme that has been implicated in regulation of insulin and leptin signaling pathways. Studies on PTP1B knockout mice and PTP1B antisense treated mice suggested that inhibition of PTP1B would be an effective strategy for the treatment of type II diabetes and obesity. Here we report the X-ray structure of PTP1B in complex with compound IN1834-146C (PDB ID 4I8N). The crystals belong to P3121 space group with cell dimensions (a = b = 87.89 Å, c = 103.68 Å) diffracted to 2.5 Å. The crystal structure contained one molecule of protein in the asymmetric unit and was solved by molecular replacement method. The compound engages both catalytic site and allosteric sites of PTP1B protein. We described the molecular interaction of the compound with the active site residues of PTP1B in this crystal structure report.
Keywords: Protein tyrosine phosphatases (PTP1B), T cell PTP (TCPTP) and X-Ray Crystallography.
Protein & Peptide Letters
Title:X-Ray Structure of PTP1B in Complex with a New PTP1B Inhibitor
Volume: 21 Issue: 1
Author(s): M.V.V.V. Sekhar reddy, Chakshumathi Ghadiyaram, Sunil Kumar Panigrahi, Narasimha Rao Krishnamurthy, Subramanya Hosahalli, Arun P. Chandrasekharappa, Deepankar Manna, Sangamesh E. Badiger, Pramod K. Dubey and Lakshmi Narasu Mangamoori
Affiliation:
Keywords: Protein tyrosine phosphatases (PTP1B), T cell PTP (TCPTP) and X-Ray Crystallography.
Abstract: Protein tyrosine phosphatase 1B (PTP1B) is a prototype non receptor cytoplasmic PTPase enzyme that has been implicated in regulation of insulin and leptin signaling pathways. Studies on PTP1B knockout mice and PTP1B antisense treated mice suggested that inhibition of PTP1B would be an effective strategy for the treatment of type II diabetes and obesity. Here we report the X-ray structure of PTP1B in complex with compound IN1834-146C (PDB ID 4I8N). The crystals belong to P3121 space group with cell dimensions (a = b = 87.89 Å, c = 103.68 Å) diffracted to 2.5 Å. The crystal structure contained one molecule of protein in the asymmetric unit and was solved by molecular replacement method. The compound engages both catalytic site and allosteric sites of PTP1B protein. We described the molecular interaction of the compound with the active site residues of PTP1B in this crystal structure report.
Export Options
About this article
Cite this article as:
reddy Sekhar M.V.V.V., Ghadiyaram Chakshumathi, Panigrahi Kumar Sunil, Krishnamurthy Rao Narasimha, Hosahalli Subramanya, Chandrasekharappa P. Arun, Manna Deepankar, Badiger E. Sangamesh, Dubey K. Pramod and Mangamoori Narasu Lakshmi, X-Ray Structure of PTP1B in Complex with a New PTP1B Inhibitor, Protein & Peptide Letters 2014; 21 (1) . https://dx.doi.org/10.2174/09298665113209990089
DOI https://dx.doi.org/10.2174/09298665113209990089 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antihypertensive Therapy in Children: Differences in Medical Approach Between the United States and Europe
Current Medicinal Chemistry Interpretable SMILES-based QSAR Model of Inhibitory Activity of Sirtuins 1 and 2
Combinatorial Chemistry & High Throughput Screening The Role of Nitric Oxide on Endothelial Function
Current Vascular Pharmacology TRAIL as Biomarker and Potential Therapeutic Tool for Cardiovascular Diseases
Current Drug Targets Pleiotropic Effects of Statins in Atherosclerotic Disease: Focus on the Antioxidant Activity of Atorvastatin
Current Topics in Medicinal Chemistry Osteoarthritis: The Need for Innovative Therapeutic Interventions
Current Rheumatology Reviews Meet the Editorial Board
Current Drug Targets Targeting the Immune System in Cancer
Current Pharmaceutical Biotechnology How and When Environmental Agents and Dietary Factors Affect the Course of Alzheimers Disease: The “LEARn” Model (Latent Early-Life Associated Regulation) May Explain the Triggering of AD
Current Alzheimer Research Withdrawal Notice: A Panoramic View on the Phytochemical, Nutritional and Therapeutic value of Ziziphus mauritiana Lam.: A Comprehensive Review
Mini-Reviews in Medicinal Chemistry Effect of Electromagnetic Field on the Polymerization of Microtubules Extracted from Rat Brain
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Exploring Plausible Therapeutic Targets for Alzheimer's Disease using Multi-omics Approach, Machine Learning and Docking
Current Topics in Medicinal Chemistry Diabetes-induced Proteome Changes Throughout Development
Endocrine, Metabolic & Immune Disorders - Drug Targets Preface [Hot Topic: Complex Carbohydrates (Guest Editors: Nasir-ud-Din and Daniel C. Hoessli)]
Current Organic Chemistry VEGF and Colon Cancer Growth Beyond Angiogenesis: Does VEGF Directly Mediate Colon Cancer Growth Via a Non-angiogenic Mechanism?
Current Pharmaceutical Design Databases and Software for NMR-Based Metabolomics
Current Metabolomics Bioactive Flavonoids from Cornus mas L. Fruits
Mini-Reviews in Organic Chemistry The Complexity of Aging: Cancer Risk Among Elderly People and Infectious Risk Among Those with Cancer
Anti-Cancer Agents in Medicinal Chemistry The Current WHO Classification of Tumours of the Central Nervous System: Histopathology and Additional Diagnostic Methods
Current Medical Imaging A Review of Dietary Influences on Cardiovascular Health: Part 1: the role of Dietary Nutrients
Cardiovascular & Hematological Disorders-Drug Targets